| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/11/2008 | EP1928858A1 Solid salt forms of a pyrrole substituted 2-indolinone |
| 06/11/2008 | EP1928846A2 Triazole compounds that modulate hsp90 activity |
| 06/11/2008 | EP1928843A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 06/11/2008 | EP1928837A2 18,21-didesoxymacbecin derivatives for the treatment of cancer |
| 06/11/2008 | EP1928508A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 06/11/2008 | EP1928497A2 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 06/11/2008 | EP1928495A2 Antibody-mediated enhancement of immune response |
| 06/11/2008 | EP1928494A2 Combination therapy for immunostimulation |
| 06/11/2008 | EP1928492A2 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 06/11/2008 | EP1928469A1 Fulvestrant formulation |
| 06/11/2008 | EP1928462A1 Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 06/11/2008 | EP1751183A4 Fas associated factor 1 |
| 06/11/2008 | EP1720540B1 Satraplatin for treating resistant or refractory tumors |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | EP1480984B1 Condensed camptothecins as antitumor agents |
| 06/11/2008 | EP1463501B1 Cis-imidazolines as mdm2 inhibitors |
| 06/11/2008 | EP1392334B1 Therapeutic methods using herbal compositions |
| 06/11/2008 | EP1239885B1 Interventions to mimic the effects of calorie restriction |
| 06/11/2008 | EP1086137B1 Composition and method for modulating dendritic cell-t cell interaction |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | CN101198623A Methods and compositions for modulating and detecting WISP activity |
| 06/11/2008 | CN101198621A Molecules and chimeric molecules thereof |
| 06/11/2008 | CN101198607A Phenylacetamides suitable as protein kinase inhibitors |
| 06/11/2008 | CN101198603A 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors |
| 06/11/2008 | CN101198590A Novel pyridine derivative and pyrimidine derivative (3) |
| 06/11/2008 | CN101198586A Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 06/11/2008 | CN101195822A High-endophilicity targeting amalgamation protein |
| 06/11/2008 | CN101195657A Type I cell factor receptor sample molecule, encoding gene and application thereof |
| 06/11/2008 | CN101195638A Trinuclear phosphamide ester compounds containing tegafur and aza-silicon |
| 06/11/2008 | CN101195625A Antineoplastic medicament antifolate, its salt and midbody |
| 06/11/2008 | CN101195616A Compound with antineoplastic activity, production method and application thereof |
| 06/11/2008 | CN101195609A Method for producing 5,6-dimethyl xanthenone-4-acetic acid, derivant and pharmaceutical formulation produced with the method |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN101195601A 2-dihydro indolone derivant, preparation method and application thereof |
| 06/11/2008 | CN101195589A Synthesis of temozolomide and analogs |
| 06/11/2008 | CN101195032A Method for preparing coupled article of polyasparamide derivant and adriablastina, and uses thereof |
| 06/11/2008 | CN101195028A Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/2008 | CN101195022A Chinese medicine prescription for curing tumor |
| 06/11/2008 | CN101194925A Prescription of anticancer abolish poison medicament, preparing and taking method thereof |
| 06/11/2008 | CN101194920A Lithospermum and application of its active ingredient in preparing medicament for treating tumour stem cell |
| 06/11/2008 | CN101194919A Hippophae rhamnoides seed oil fatty milk injection and technique of preparing the same |
| 06/11/2008 | CN101194917A Grifola frondosa oral liquid rich in gastrodine, organic selenium and method for preparing the same |
| 06/11/2008 | CN101194902A Dropping pills containing ubenimex and method for preparing the same |
| 06/11/2008 | CN101194705A Gourmet powder with health care function |
| 06/11/2008 | CN100393814C A natural fluorescent dye obtained from a marine invertebrate, compositions from a marine invertebrate, compositions containing the said dye and their use |
| 06/11/2008 | CN100393746C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393745C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393731C Water soluble phosphate ester salt ofú¿Zú®-3'-hydroxy-3,4',5-trimethoxydiphenyl ethylene, and its preparation method ,pharmaceutical composition and uses |
| 06/11/2008 | CN100393724C 20-esterifiable camptothecine derivative and method for making same and pharmaceutical combination and uses |
| 06/11/2008 | CN100393356C Modified cytokines for use in cancer therapy |
| 06/11/2008 | CN100393346C Traditional Chinese medicine for treating leuhemia |
| 06/11/2008 | CN100393329C Chinese medicine preparation compound Huangdai tablet for treating leukemia and its preparing method |
| 06/11/2008 | CN100393327C Chewing tablet of Taishan radix cynanchi bungei, its preparing method and use |
| 06/11/2008 | CN100393326C Use of Chinese sealavender for preparing antineoplastic drug |
| 06/11/2008 | CN100393319C Astragaloside cyclodextrin clathrate, its preparation and preparing mehtod |
| 06/11/2008 | CN100393308C Use of Coleus forskohlii extract agent in tumor growth and preliferation inhibiting agent |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385059 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | US7385042 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7385029 crystallizing amorphous N2-(N,N-dimethyl-L-valyl)-N-[(1 S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide (TZT-1027) or salts from diethyl ether or ethyl acetate or mixed solvent; stability |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384940 Calibration kinase resistance; anticancer agents |
| 06/10/2008 | US7384935 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals |
| 06/10/2008 | US7384925 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 06/10/2008 | US7384919 Nontoxic; spray drying or freeze drying |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384631 Contacting myeloid cells in a sample with a ligand directed against p75/AIRM1(75 kd adhesion inhibitory receptor molecule1) receptor, and determining binding of the ligand |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2322790C Granulatimide derivatives for use in cancer treatment |
| 06/10/2008 | CA2286330C Anti-vegf antibodies |
| 06/10/2008 | CA2252584C Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
| 06/05/2008 | WO2008067481A1 Aza-indolyl compounds and methods of use |
| 06/05/2008 | WO2008067450A2 6-alkoxyalkyl estradiol derivatives and methods of use |
| 06/05/2008 | WO2008067270A1 Macrocyclic grb2 sh2 domain-binding inhibitors |
| 06/05/2008 | WO2008066854A2 Methods and compositions for inducing apoptosis in cancer cells |
| 06/05/2008 | WO2008066807A1 Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer |
| 06/05/2008 | WO2008066526A1 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl n,n,n',n'-tetrakis(2 -chloroethyl)phosphorodiamidates |
| 06/05/2008 | WO2008066515A1 2-({2-oxo-2-[(pyridin-3-ylmethyl)amino]ethyl}sulfonyl)ethyl n,n,n',n'-tetrakis(2-chloroethyl)phosphorodiamidate |
| 06/05/2008 | WO2008066402A1 Use of malachite green in the form of drug for treating malignant neoplasms |
| 06/05/2008 | WO2008066301A1 Anticancer composition containing naphthoquinone-based compound for intestine delivery system |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008066057A1 Control of cell proliferation targeted for iqgap3 |
| 06/05/2008 | WO2008066032A1 Lymphangiogenesis inhibitory factor |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065752A1 Immunotherapeutic agent containing dirna as active ingredient |
| 06/05/2008 | WO2008065738A1 Bone defect filler, release-controlled carrier, and their production methods |
| 06/05/2008 | WO2008065726A1 Telomelysin-containing agent for breaking antitumor tolerance |